Real-World Experience of Immune-Checkpoint Inhibitors in Older Patients with Advanced Cutaneous Squamous Cell Carcinoma.

Luke S McLeanAnnette M LimMathias BresselAlesha A ThaiDanny Rischin

Published in: Drugs & aging (2024)

ICIs have demonstrated efficacy and have an acceptable safety profile among older patients with advanced CSCC, with comparable efficacy to what has been demonstrated in current clinical trials.

Keyphrases

squamous cell carcinoma
clinical trial
physical activity
middle aged
randomized controlled trial
community dwelling
radiation therapy
phase ii
open label
phase iii